Fetal treatment and long-term neonatal outcomes in severe maternal red cell alloimmunization - a single-centre experience. [PDF]
Mesarič VA+7 more
europepmc +1 more source
Persistence of Lymphocytotoxic Antibodies in Patients in the Trial to Reduce Alloimmunization to Platelets: Implications for Using Modified Blood Products [PDF]
Sherrill J. Slichter+6 more
openalex +1 more source
Phenotypic Identification of Blood Groups in Blood Donors: A Peruvian Multicenter Analysis. [PDF]
Yovera-Ancajima CDP+7 more
europepmc +1 more source
Characterization of severity of hemolytic disease of the fetus and newborn due to Rhesus antigen alloimmunization. [PDF]
Krumme AA+6 more
europepmc +1 more source
Alloimmunization to Red Cell Antigens in Liver and Multivisceral Transplant Patients
Sherry Shariatmadar+4 more
openalex +1 more source
Red Cell Phenotyping of Rh and Kell in Voluntary Blood Donors at a Tertiary Care Center in Jamnagar. [PDF]
Davad DP, Panucha RP, Patel KJ, Nagda J.
europepmc +1 more source
Comprehensive Characterization of Anti-HLA and Non-HLA Antibodies in Patients on Kidney Transplant Waiting List and Evaluation of Their Impact on Alloimmunization Risk and Dialysis Treatment. [PDF]
Mujić Franić A+3 more
europepmc +1 more source
Anti-HLA antibody formation increases the chances of platelet refractoriness in platelet-transfused patients: a systematic review with meta-analysis. [PDF]
Cabral LJB+5 more
europepmc +1 more source
CRISPR-Cas9-driven antigen conversion of clinically relevant blood group systems. [PDF]
Boccacci Y+3 more
europepmc +1 more source